|
Press Releases |
|
|
|
Monday, January 18, 2021 |
|
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SN1011 in China |
SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the first healthy subject was successfully dosed in the Phase I clinical trial of SN1011 more info >> |
|
Monday, November 23, 2020 |
|
SinoMab Commenced Construction of its China Headquarters |
SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
Thursday, July 23, 2020 |
|
SinoMab entered into Strategic Collaboration with D2M |
SinoMab BioScience Limited ("SinoMab" of the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
Wednesday, June 10, 2020 |
|
SinoMab Announces Clinical Results on its First-in-target SM03 at EULAR 2020 Congress |
SinoMab BioScience Limited ("SinoMab" or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases more info >> |
|
Friday, January 10, 2020 |
|
SinoMab Granted the "Most Popular Newly Listed Company" Award |
SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen. more info >> |
|
Wednesday, November 20, 2019 |
|
Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate SM03 Phase III Clinical Trial for the Treatment RA |
SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce its latest progress of SM03 phase III clinical trial for the treatment rheumatoid arthritis. more info >> |
|
Wednesday, October 30, 2019 |
|
SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK |
SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
M&A Securities and NewParadigm Underwrites Rights Issue with Warrants for Siab Holdings Berhad's Acquisition of Taghill
May 7, 2024 16:00 HKT/SGT
|
|
|
Lithuanian Biotech Pioneer 'Nando' Embarks on Global Expansion With New Management Team and Innovative Production Line
May 7, 2024 15:00 HKT/SGT
|
|
|
HKTDC launches International Healthcare Week
May 7, 2024 14:00 HKT/SGT
|
|
|
MHI Agrees to Collaborate with Chiyoda Corporation for Licensing of CO2 Capture Technologies
May 7, 2024 13:49 JST
|
|
|
Mastering the AI Revolution: MetaHomes Ushers Intelligent AI Features into Real Estate Amidst Dubai's Booming Market
May 7, 2024 12:00 HKT/SGT
|
|
|
Alpha Trends Introduces Solution for CFD Trading, Combining AI and Expert Financial Guidance
May 7, 2024 08:00 HKT/SGT
|
|
|
Armor Unveils a Disruptive Approach to Managed Detection and Response
May 6, 2024 23:00 HKT/SGT
|
|
|
CyberSecID Conference 2024 - Zero Trust for Today, Zero Worries for Tomorrow
May 6, 2024 22:00 HKT/SGT
|
|
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs
May 6, 2024 21:05 HKT/SGT
|
|
|
Yee Hop Holdings' (1662.HK) Subsidiary APEL Triumphs with Three Medals at the International Exhibition of Inventions Geneva
May 6, 2024 18:42 HKT/SGT
|
|
|
2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific
May 6, 2024 18:00 HKT/SGT
|
|
|
SMEStreet Celebrates 10 Years of Serving Indian MSMEs
May 6, 2024 17:20 HKT/SGT
|
|
|
World Blockchain Summit: Pioneering Insights and Strategic Partnerships Ignite in Dubai
May 6, 2024 16:50 HKT/SGT
|
|
|
Future of Video in India Sees Much Optimism for Growth with Technology as the Enabler for the Consumer
May 6, 2024 15:40 HKT/SGT
|
|
|
Rockbird media Presents Retail & E-commerce Summit Asia 2024 - 'Retail Revolution: Setting the Landscape Ablaze' in Manila
May 6, 2024 15:00 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|